MADISON, Wis., Oct. 17, 2011 /PRNewswire/ -- Cellular Dynamics International (CDI) today announced that it was named as the overall Gold winner in The Wall Street Journal Technology Innovation Awards.
The Wall Street Journal 2011 Technology Innovation Awards are determined by a panel of independent judges who evaluated significant innovations that occurred in 2010. Six-hundred-five applicants competed for the award in 16 categories. Of these, the panel chose 35 winners and runners-up.
"Medical research has been challenged by the lack of access to a consistent supply of human cells, such as heart or brain cells," said Dr. James Thomson, CDI founder and chief scientific officer. "Research today employs proxies, such as animal cells, tumor cell lines or cadaveric tissue, none of which truly reflect human biology. I founded CDI based on my desire to make pluripotent stem cells and human tissue cells widely available to accelerate discoveries in human health and biological research. CDI's production technology and capacity provide this access, enabling us to manufacture human material from anyone. CDI has overcome the scalability challenges, mass producing industrial quantities of human cells in high quality and purity."
CDI has developed a proprietary manufacturing process in which cells isolated from a doctor's office standard blood draw from virtually anyone can be reprogrammed into that individual's personal pluripotent stem cell line. CDI can then differentiate these stem cells into any cell type in the human body in industrial quantity, quality and purity so that scientists have a consistent supply of human cells from specific individuals. Two human cell products, iCell® Cardiomyocytes (heart muscle cells) and iCell Endothelial Cells (blood vessel cells), have been launched over the past two years, with neurons and liver cells alrea
|SOURCE Cellular Dynamics International, Inc.|
Copyright©2010 PR Newswire.
All rights reserved